Response to letter to the editor regarding 'Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome'
Liver Int. 2024 Aug;44(8):2093-2094.
doi: 10.1111/liv.15949.
Epub 2024 Jun 18.
1 Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy, Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden.
2 Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
3 Division of Endocrinology, Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
4 Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.
5 Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.